Literature DB >> 31239815

Delays in diagnosis of nephrotic syndrome in children: A survey study.

Asha Hollis1, Allison Dart2, Catherine Morgan3, Cherry Mammen4, Michael Zappitelli5, Rahul Chanchlani6, Susan Samuel1.   

Abstract

BACKGROUND: Clinical experience suggests that childhood nephrotic syndrome is frequently diagnosed incorrectly, leading to delays in providing effective treatment. We hypothesized that the health care setting is an important determinant of diagnostic success, with implications for the patient and family health care experience. Our objectives were: (1) to characterize the relationship between diagnostic success and health care setting for the diagnosis of nephrotic syndrome, (2) to determine types and frequencies of incorrect diagnoses, and (3) to understand the burden placed on patients and families as a result of incorrect and incomplete diagnoses.
METHODS: A survey was conducted by phone or in-person with legal guardians of children 1 to 18 years diagnosed with nephrotic syndrome within 24 months before the study. The survey elicited information on type of health care setting utilized (e.g., family practice, emergency room) and on diagnoses and treatments.
RESULTS: Seventy-four patients with varying ethnicities and socioeconomic profiles (37 male, 37 female, median age 4.8 years, range: 1.2 to 14.8) were included from four Canadian paediatric nephrology centres. Proportions of diagnostic success were high in emergency and paediatric care settings (66% and 64% correct, respectively), but low in primary care settings (17% family practice and 17% walk-in clinic, respectively). Diagnostic delays ranged from 0 to 428 days (median 9.5, interquartile range [IQR] = 20.5). "Allergies" was the most common incorrect diagnosis (47%). Parents and legal guardians reported missed work (55%) and added expenses (50%) prior to obtaining a correct diagnosis.
CONCLUSIONS: Childhood nephrotic syndrome is often incorrectly diagnosed, especially in primary care settings.

Entities:  

Keywords:  Diagnostic delay; Nephrotic syndrome; Patient experience; Rare disease

Year:  2018        PMID: 31239815      PMCID: PMC6587688          DOI: 10.1093/pch/pxy165

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  7 in total

1.  The cost of ambulatory care in alternative settings: a review of major research findings.

Authors:  S H Altman; E Socholitzky
Journal:  Annu Rev Public Health       Date:  1981       Impact factor: 21.981

2.  The common problem of rare disease in general practice.

Authors:  Andrew W Knight; Timothy P Senior
Journal:  Med J Aust       Date:  2006-07-17       Impact factor: 7.738

Review 3.  Rare childhood diseases: how should we respond?

Authors:  Y Zurynski; K Frith; H Leonard; E Elliott
Journal:  Arch Dis Child       Date:  2008-08-06       Impact factor: 3.791

Review 4.  Nephrotic syndrome in childhood.

Authors:  Allison A Eddy; Jordan M Symons
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

Review 5.  Nephrotic syndrome.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2012-05-30       Impact factor: 5.319

6.  The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: overview of design and methods.

Authors:  Susan Samuel; Shannon Scott; Catherine Morgan; Allison Dart; Cherry Mammen; Rulan Parekh; Alberto Nettel-Aguirre; Allison Eddy; Rachel Flynn; Maury Pinsk; Andrew Wade; Steven Arora; Geneviève Benoit; Martin Bitzan; Robin Erickson; Janusz Feber; Guido Filler; Pavel Geier; Colette Girardin; Silviu Grisaru; James Tee; Kyle Kemp; Michael Zappitelli
Journal:  Can J Kidney Health Dis       Date:  2014-07-22

7.  Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.

Authors:  Susanne Blöß; Christian Klemann; Ann-Katrin Rother; Sandra Mehmecke; Ulrike Schumacher; Urs Mücke; Martin Mücke; Christiane Stieber; Frank Klawonn; Xiaowei Kortum; Werner Lechner; Lorenz Grigull
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

  7 in total
  2 in total

1.  Results of a Patient Reported Experience Measure (PREM) to measure the rare disease patients and caregivers experience: a Spanish cross-sectional study.

Authors:  Mercedes Guilabert; Alba Martínez-García; Marina Sala-González; Olga Solas; José Joaquín Mira
Journal:  Orphanet J Rare Dis       Date:  2021-02-05       Impact factor: 4.123

2.  Absence of Long Noncoding RNA H19 Promotes Childhood Nephrotic Syndrome through Inhibiting ADCK4 Signal.

Authors:  Jinwen Xu; Tingting Ge; Hongxia Zhou; Lin Zhang; Liping Zhao
Journal:  Med Sci Monit       Date:  2020-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.